ArticleNano today2021
TiO
Open access · hybridAbstract read
In one paragraph
Article in Nano today, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
8.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 118 citations in OpenAlex.
- Precision-Engineered Silver Single-Atom Carbon Dot Nanozymes for Theranostic Management of Acute Kidney Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Antiviral drug discovery and development: challenges and future directions.Signal transduction and targeted therapy · 2026Review
- Antimicrobial Nanozymes: Structure-Activity-Guided Design, Synergy, and Applications.Research (Washington, D.C.) · 2026Review
- Unraveling the Role of the Multifunctional Groups in the Adsorption of l-Cysteine on Rutile TiOJournal of the American Chemical Society · 2025Article
- Emerging two-dimensional nanomaterial and its modifications for enhanced antiviral applications: a review.Royal Society open science · 2025Review
- Light-activated multimodal nanoplatform for enhanced synergistic therapy of breast cancer.Scientific reports · 2025Article
- Nanozymes: a bibliometrics review.Journal of nanobiotechnology · 2024Review
- Rapid solar-driven atmospheric water-harvesting with MAF-4-derived nitrogen-doped nanoporous carbon.Chemical science · 2024Article
- Single-atom nanozymes shines diagnostics of gastrointestinal diseases.Journal of nanobiotechnology · 2024Review
- A ruthenium single atom nanozyme-based antibiotic for the treatment of otitis media caused byFrontiers in chemistry · 2024Article
- Construction of Thiadiazole-Linked Covalent Organic Frameworks via Facile Linkage Conversion with Superior Photocatalytic Properties.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023Article
- The shape-dependent inhibitory effect of rhein/silver nanocomposites on porcine reproductive and respiratory syndrome virus.Discover nano · 2023Article
- Impact of surface cooling on the water harvesting efficiency of nanostructured window glass.RSC advances · 2023Article
- Utilizing nanozymes for combating COVID-19: advancements in diagnostics, treatments, and preventative measures.Journal of nanobiotechnology · 2023Review
- Synthesis and application of titanium dioxide photocatalysis for energy, decontamination and viral disinfection: a review.Environmental chemistry letters · 2023Review
- Molecular insights of nanozymes from design to catalytic mechanism.Science China. Chemistry · 2023Review
- Galectin-3 binding protein stimulated IL-6 expression is impeded by antibody intervention in SARS-CoV-2 susceptible cell lines.Scientific reports · 2022Article
- Nanozymes: Versatile Platforms for Cancer Diagnosis and Therapy.Nano-micro letters · 2022Review
- Exploration of nanozymes in viral diagnosis and therapy.Exploration (Beijing, China) · 2022Review
- Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19.Frontiers in bioengineering and biotechnology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 5 institutions in 1 country.
Daji WangShenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China.
Bin ZhangShenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China.
Hui DingShenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China.
Dan LiuCAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Jianquan XiangSchool of Basic Medical Sciences, Southwest Medical University, Sichuan 646000, China.
Xuejiao J GaoCollege of Chemistry and Chemical Engineering, Jiangxi Normal University, Nanchang 330022, China.
Xuehui ChenCAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Zhongjun LiShenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China.
Lei YangShenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China.
Hongxia DuanCAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Jiyan ZhengCAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Zheng LiuCAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Bing JiangCAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Yang LiuShenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China.
Ni XieShenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China.
Han ZhangSZU-NUS Collaborative Innovation Center for Optoelectronic Science & Technology, International Collaborative Laboratory of 2D Materials for Optoelectronics Science and Technology of Ministry of Education College of Physics and Optoelectronic Engineering Shenzhen University, Shenzhen 518060, China.
Xiyun YanShenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China.
Kelong FanCAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Guohui NieShenzhen Key Laboratory of nanozymes and Translational Cancer Research, Department of Otolaryngology, and Institute of Translational Medicine, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China.
Chinese Academy of Sciences · CNShenzhen University Health Science Center · CNJiangxi Normal University · CNShenzhen University · CNSouthwest Medical University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO
Indexed as
Anti-SARS-CoV2NeutralizationPeroxidase-like activityReactive oxygen speciesSingle-atom nanozyme
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.